| FENC Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the FENC market cap history going back to 11/13/2017:
Also see: FENC Shares Outstanding History and FENC YTD Return |
FENC Market Cap History — Fennec Pharmaceuticals Capitalization Over Time
As of 8/11/2026 Fennec Pharmaceuticals has a market cap of 448.16 million. Investors often follow the FENC market cap history to compare the size of the company over time.
This page shows FENC market capitalization trends over time, with 36 market cap datapoints presented, dating back to 11/13/2017.
| FENC Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FENC Historical Market Cap: +12.37% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| FENC Stock Price Chart |
| About Fennec Pharmaceuticals Inc |
| Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on its product candidate PEDMARK. It sells its product through a field force, including Regional Pediatric Oncology Specialists and medical science liaisons who are helping to educate the medical communities and patients about cisplatin induced ototoxicity and its programs supporting patient access to PEDMARK. PEDMARK is a Food and Drug Administration approved therapy indicated to reduce the risk of ototoxicity associated with cisplatin treatment in pediatric patients with localized, non-metastatic, solid tumors. We show 36 historical shares outstanding datapoints in our FENC shares outstanding history coverage, used to compute FENC market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing FENC market cap history over the course of time is important for investors interested in comparing FENC's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of FENC versus a peer is one thing; comparing FENC market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like FENC can fluctuate over the course of history. With this page we aim to empower investors researching FENC by allowing them to research the FENC market cap history. |
| FENC Current Stock Quote |
Quotes delayed 20 minutes  Free FENC Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| FENC Share Performance |
| Market Cap Peers |
| Fennec Pharmaceuticals (FENC) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
FEXD Market Cap History FGMC Market Cap History FGNA Market Cap History FHL Market Cap History FHLT Market Cap History FIAC Market Cap History FICV Market Cap History FIII Market Cap History FINM Market Cap History FINX Market Cap History More Miscellaneous companies » |
FENC Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
